Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Big Pharma-backed GlycoEra counting days to clinic with $130M raise for protein degraders
Fierce Biotech
Tuesday, May 27, 2025 - 11:17am
tags:
GlycoEra, funding, protein degradation, autoimmune diseases
Bayer secures EU nod for 6 month Eylea treatment
Investing.com
Tuesday, May 27, 2025 - 11:12am
tags:
Bayer, EMA, Eylea
Turning the page: Novo’s CEO transition reflects Big Pharma’s era of change
Pharma Voice
Tuesday, May 27, 2025 - 11:10am
tags:
Pharma CEOs, Novo Nordisk, JNJ, AbbVie, Merck, pharma industry
ASCO 25: Merus bispecific scores again in HNSCC
Pharmaphorum
Tuesday, May 27, 2025 - 11:06am
tags:
ASCO 2025, Merus, petosemtamab, head and neck cancer, bispecifics
Sanofi admits giving free Olympics tickets to patients
Pharmaphorum
Tuesday, May 27, 2025 - 11:04am
tags:
Sanofi, PMCPA, UK, patients, Olympics
Merus hails 'unprecedented' survival on solid tumor bispecific, sparking stock jump
Fierce Biotech
Friday, May 23, 2025 - 9:29am
tags:
ASCO 2025, Merus, solid tumors
Navigating the FDA’s accelerated approval pathways for oncology drugs
Clinical Trials Arena
Friday, May 23, 2025 - 8:48am
tags:
FDA, oncology, cancer, accelerated approvals
Gilead Sciences (GILD) announces positive data from Phase 3 Trodelvy study
Street Insider
Friday, May 23, 2025 - 8:45am
tags:
Gilead Sciences, Trodelvy, clinical trials, triple negative breast cancer
Merit buys hemostatic device maker Biolife for $120M
Medtech Dive
Friday, May 23, 2025 - 8:34am
tags:
Medtech, M&A, Merit, BioLife Delaware, StatSeal, WoundSeal
Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial
Clinical Trials Arena
Friday, May 23, 2025 - 8:31am
tags:
Astellas, Pfizer, clinical trials, Xtandi, metastatic hormone-sensitive prostate cancer, prostate cancer
5 key takeaways from the MAHA commission report
Axios
Friday, May 23, 2025 - 8:29am
tags:
Donald Trump, Robert F Kennedy Jr., MAHA, HHS
ASCO 25: Roche places Itovebi marker in breast cancer
Pharmaphorum
Friday, May 23, 2025 - 8:23am
tags:
ASCO 2025, Rocher, Itovebi, breast cancer
ASCO: Roche, Jazz's Zepzelca small cell lung cancer win leaves room for improvement
Fierce Pharma
Thursday, May 22, 2025 - 9:29pm
tags:
Roche, Jazz Pharma, Tecentriq, Zepzelca, small cell lung cancer, ASCO 2025
GSK’s Nucala wins U.S. nod as first IL-5 biologic for COPD
Drug Discovery and Development
Thursday, May 22, 2025 - 9:25pm
tags:
GSK, Nucala, COPD, FDA
Sanofi opens doors to $130M 'flagship' US office facility in New Jersey
Fierce Pharma
Thursday, May 22, 2025 - 9:22pm
tags:
Sanofi, New Jersey
AI tool could help doctors ID breast cancers vulnerable to Enhertu
BioPharma Dive
Thursday, May 22, 2025 - 9:19pm
tags:
diagnostics, Medtech, breast cancer, artificial intelligence, AstraZeneca, Daiichi Sankyo, Enhertu
Vaccine advisers to the FDA recommended changes to COVID vaccines
NPR
Thursday, May 22, 2025 - 9:17pm
tags:
COVID-19, vaccines, FDA
FDA proposes FY 2026 budget; Makary offers details on staff attrition
RAPS.org
Thursday, May 22, 2025 - 9:15pm
tags:
FDA, regulatory, Marty Makary
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Fierce Biotech
Thursday, May 22, 2025 - 11:42am
tags:
Sanofi, M&A, Vigil Neuroscience, Alzheimer's disease
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
Motley Fool
Thursday, May 22, 2025 - 11:40am
tags:
Eli Lilly, Novo Nordisk, Zebound, Wegovy, obesity, weight loss

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.